ABSTRACT
Previous studies showed a prominent role of the medial prefrontal cortex (mPFC), especially the prelimbic (PL) and infralimbic (IL) subregions, in behavioral and physiological responses to stressful stimuli. Nevertheless, the local neurochemical mechanisms involved are not completely understood. In this sense, previous studies identified cholinergic terminals within the mPFC, and stressful stimuli increased local acetylcholine release. Despite these pieces of evidence, the specific role of cholinergic neurotransmission in different subregions of the mPFC controlling the cardiovascular responses to stress has never been systematically evaluated. Therefore, the purpose of this study was to investigate the involvement of cholinergic neurotransmission present within PL and IL in cardiovascular responses to an acute session of restraint stress in rats. For this, rats received bilateral microinjection of the choline uptake inhibitor hemicholinium-3 before exposure to restraint stress. The arterial pressure and heart rate (HR) increases and the decrease in tail skin temperature as an indirect measurement of sympathetically-mediated cutaneous vasoconstriction were recorded throughout the restraint stress session. The results showed that the depletion of acetylcholine within the PL caused by local microinjection of hemicholinium-3 decreased the tachycardia to restraint stress, but without affecting the pressor response and the drop in tail skin temperature. Conversely, IL treatment with hemicholinium-3 decreased the restraint-evoked pressor response and the sympathetically-mediated cutaneous vasoconstriction without interfering with the HR response. Taken together, these results indicate functional differences of cholinergic neurotransmission within the PL and IL in control of cardiovascular and autonomic responses to stressful stimuli.
Subject(s)
Acetylcholine/physiology , Autonomic Nervous System/physiology , Blood Pressure/physiology , Cholinergic Agents/pharmacology , Heart Rate/physiology , Neurotransmitter Uptake Inhibitors/pharmacology , Prefrontal Cortex/physiology , Stress, Psychological/physiopathology , Synaptic Transmission/physiology , Animals , Blood Pressure/drug effects , Heart Rate/drug effects , Hemicholinium 3/pharmacology , Prefrontal Cortex/drug effects , Rats , Restraint, PhysicalABSTRACT
BACKGROUND/AIMS: In this study, we evaluated the functional impact of facilitatory presynaptic adenosine A2A and muscarinic M1 receptors in the recovery of neuromuscular tetanic depression caused by the blockage of high-affinity choline transporter (HChT) by hemicholinium-3 (HC-3), a condition that mimics a myasthenia-like condition. METHODS: Rat diaphragm preparations were indirectly stimulated via the phrenic nerve trunk with 50-Hz frequency trains, each consisting of 500-750 supramaximal intensity pulses. The tension at the beginning (A) and at the end (B) of the tetanus was recorded and the ratio (R) B/A calculated. RESULTS: Activation of A2A and M1 receptors with CGS21680 (CGS; 2 nmol/L) and McN-A-343c (McN; 3 µmol/L) increased R values. Similar facilitatory effects were obtained with forskolin (FSK; 3 µmol/L) and phorbol 12-myristate 13-acetate (PMA; 10 µmol/L), which activate adenylate cyclase and protein kinase C respectively. HC-3 (4 µmol/L) decreased transmitter exocytosis measured by real-time videomicroscopy with the FM4-64 fluorescent dye and prevented the facilitation of neuromuscular transmission caused by CGS, McN, and FSK, with a minor effect on PMA. The acetylcholinesterase inhibitor, neostigmine (NEO; 0.5 µmol/L), also decreased transmitter exocytosis. The paradoxical neuromuscular tetanic fade caused by NEO (0.5 µmol/L) was also prevented by HC-3 (4 µmol/L) and might result from the rundown of the positive feedback mechanism operated by neuronal nicotinic receptors (blocked by hexamethonium, 120 µmol/L). CONCLUSION: Data suggest that the recovery of tetanic neuromuscular facilitation by adenosine A2A and M1 receptors is highly dependent on HChT activity and may be weakened in myasthenic patients when HChT is inoperative.
Subject(s)
Membrane Transport Proteins/physiology , Receptor, Adenosine A2A/physiology , Receptor, Muscarinic M1/physiology , Refractory Period, Electrophysiological/drug effects , (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride/pharmacology , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , Colforsin/pharmacology , Diaphragm/drug effects , Diaphragm/physiology , Hemicholinium 3/pharmacology , Neostigmine/pharmacology , Phenethylamines/pharmacology , Phrenic Nerve/drug effects , Phrenic Nerve/physiology , Rats , Rats, Wistar , Synaptic Transmission , Tetanus/drug therapy , Tetanus/physiopathology , Tetradecanoylphorbol Acetate/pharmacologyABSTRACT
In the resting state, motor neurons continuously release ACh through quantal and non-quantal mechanisms, the latter through vesicular ACh transporter (VAChT) and choline transporter (ChT). Although in skeletal muscle these mechanisms have been extensively studied, the non-quantal release (NQR) from parasympathetic neurons of airway smooth muscle has not been described. Here we corroborated that the organophosphate paraoxon (acetylcholinesterase inhibitor) induced a contraction blocked by atropine (muscarinic antagonist) in guinea-pig tracheal rings. This contraction was not modified by two blockers of evoked quantal release, tetrodotoxin (voltage-dependent Na(+) channel blocker) and ω-conotoxin GVIA (N-type Ca(2+) channel blocker), nor by the nicotinic blocker hexamethonium, suggesting that acetylcholine NQR could be responsible of the paraoxon-induced contraction. We confirmed that tetrodotoxin, and to some extent -conotoxin, abolished the evoked quantal ACh release induced by electrical field stimulation. Hemicholinium-3 (ChT inhibitor), but not vesamicol (VAChT inhibitor), caused a concentration-dependent inhibition of the response to paraoxon. The highest concentration of hemicholinium-3 left â¼75% of the response to electrical field stimulation, implying that inhibition of paraoxon-induced contraction was not due to depletion of neuronal vesicles. Non-neuronal sources of ACh released through organic cation transporters were discarded because their inhibition by quinine or corticosterone did not modify the response to paraoxon. Calcium-free medium abolished the effect of paraoxon, and NiCl(2), 2-aminoethyl diphenyl-borate and SKF 96365 partly inhibited it, suggesting that non-specific cation channels were involved in the acetylcholine NQR. We concluded that a Ca(2+)-dependent NQR of ACh is present in cholinergic nerves from guinea-pig airways, and that ChT is involved in this phenomenon.
Subject(s)
Acetylcholine/metabolism , Membrane Transport Proteins/metabolism , Trachea/metabolism , Vesicular Acetylcholine Transport Proteins/metabolism , Animals , Atropine/pharmacology , Calcium/metabolism , Cation Transport Proteins/metabolism , Cholinesterase Inhibitors/pharmacology , Electric Stimulation , Guinea Pigs , Hemicholinium 3/pharmacology , Hexamethonium/pharmacology , Male , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/innervation , Muscle, Smooth/metabolism , Neurons/drug effects , Neurons/metabolism , Organophosphates/pharmacology , Paraoxon/pharmacology , Piperidines/pharmacology , Tetrodotoxin/pharmacology , Trachea/drug effects , Trachea/innervation , omega-Conotoxin GVIA/pharmacologyABSTRACT
In this article, we will review some behavioral, pharmacological and neurochemical studies from our laboratory on mice, which might contribute to our understanding of the complex processes of memory consolidation and reconsolidation. We discuss the post-training (memory consolidation) and post-reactivation (memory reconsolidation) effects of icv infusions of hemicholinium, a central inhibitor of acetylcholine synthesis, of intraperitoneal administration of L-NAME, a non-specific inhibitor of nitric oxide synthase, of intrahippocampal injections of an inhibitor of the transcription factor NF-kappaB, and the exposure of mice to a new learning situation on retention performance of an inhibitory avoidance response. All treatments impair long-term memory consolidation and retrieval-induced memory processes different from extinction, probably in accordance with the 'reconsolidation hypothesis'.
Subject(s)
Avoidance Learning/drug effects , Hemicholinium 3/pharmacology , Memory/drug effects , NF-kappa B/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Acetylcholine/antagonists & inhibitors , Animals , Avoidance Learning/physiology , Memory/physiology , Mice , Nitric Oxide Synthase/antagonists & inhibitors , Rats , Retention, Psychology/drug effects , Retention, Psychology/physiologyABSTRACT
Co-occurrence of tobacco smoking and alcohol consumption during adolescence is frequent and well documented. However, little is known about the basic neurobiology of the combined exposure in the adolescent brain. Since nicotine is a cholinergic agonist and it has been shown that ethanol interferes with nicotinic acetylcholine receptors (nAChRs), the current work focused on cholinergic systems. From the 30th to the 45th postnatal day (PN), C57BL/6 male and female mice were exposed to nicotine free base (NIC) and/or ethanol (ETOH). Four groups were analyzed: 1) concomitant NIC (50 microg/ml in 2% saccharin to drink) and ETOH (25%, 2 g/kg i.p. injected every other day) exposure; 2) NIC exposure; 3) ETOH exposure; 4) vehicle. We assessed nAChR binding, choline acetyltransferase (ChAT) activity and [3H]hemicholinium-3 (HC-3) binding in the cerebral cortex and midbrain of mice on PN45. In the cortex, ETOH had no effect on nAChRs. In contrast, NIC produced nAChR upregulation while NIC+ETOH elicited a more pronounced effect. In the midbrain, neither ETOH nor NIC had effects on nAChRs. NIC+ETOH, however, elicited a robust nAChR upregulation. Regarding ChAT activity, treatment effects differed between males and females in the cortex. Male NIC mice presented an increase in ChAT. However, ETOH reversed this effect. In contrast, female NIC mice presented decreased ChAT activity. In the midbrain, ETOH increased ChAT. HC-3 binding was not affected. These results indicate that the central cholinergic system is a site at which nicotine and ethanol interact. This interaction might underlie the association between tobacco and alcohol consumption during adolescence.
Subject(s)
Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Parasympathetic Nervous System/drug effects , Animals , Behavior, Animal/drug effects , Biomarkers , Body Weight/drug effects , Brain/growth & development , Choline O-Acetyltransferase/metabolism , Cholinergic Agents/pharmacology , Drinking/drug effects , Drug Interactions , Female , Hemicholinium 3/pharmacology , Male , Membrane Transport Proteins/metabolism , Mice , Mice, Inbred C57BL , Organ Size/drug effects , Presynaptic Terminals/drug effects , Receptors, Nicotinic/drug effects , Receptors, Nicotinic/metabolism , Receptors, Presynaptic/drug effects , Receptors, Presynaptic/metabolism , Sexual Maturation/drug effectsABSTRACT
The cingulate cortex (CC) is involved in cardiovascular regulation. Microinjection of norepinephrine (NE) into the Cg3 area of the CC caused vasopressin release and pressor responses in unanesthetized rats. Microinjection of acetylcholine (ACh) into the lateral septal area (LSA) of unanesthetized rats caused similar vasopressin-related pressor responses. The LSA is anatomically connected to the CC and the paraventricular nucleus (PVN) of the hypothalamus, an important nucleus involved in vasopressin synthesis. Therefore, we attempted to verify if the cholinergic neurotransmission within the LSA is involved in the mediation of the pressor response to the microinjection of NE into the Cg3. Local pretreatment with lidocaine, muscimol, atropine or hemicholinium-3 microinjected into the LSA blocked the pressor response to the microinjection of NE injection into the Cg3. Conversely, pretreatment with physostigmine microinjected into the LSA potentiated the pressor response to NE injection into the Cg3. The present results indicate that the synapses in the LSA are part of the pressor pathway originating at the CC and that cholinergic neurotransmission within the LSA is involved in the mediation of the cardiovascular responses to the microinjection of NE into the Cg3.
Subject(s)
Blood Pressure/drug effects , Gyrus Cinguli/drug effects , Norepinephrine/pharmacology , Septum of Brain/physiology , Acetylcholine/pharmacology , Anesthetics, Local/pharmacology , Animals , Atropine/pharmacology , Cholinergic Agents/pharmacology , Cholinesterase Inhibitors/pharmacology , Drug Interactions , Gyrus Cinguli/physiology , Hemicholinium 3/pharmacology , Lidocaine/pharmacology , Male , Microinjections/methods , Muscarinic Antagonists/pharmacology , Physostigmine/pharmacology , Rats , Rats, Wistar , Septum of Brain/drug effects , Vasopressins/metabolismABSTRACT
The mechanism by which muscarinic or nicotinic agonists produce antinociception has been the subject of several studies. In the present investigation, we used intrathecal administration of drugs to rats to show that muscarinic or nicotinic agonists such as bethanechol (BCh) and dimethylphenylpiperazinium (DM), respectively, dose-dependently increased the tail flick latency and reduced the pain produced by a surgical incision performed on the plantar aspect of a hind paw. The effects of BCh in both tests were inhibited by the previous intrathecal administration of atropine, but not mecamylamine (muscarinic and nicotinic antagonists, respectively). Mecamylamine significantly reduced the effects of DM in both tests. Atropine significantly reduced the effect of DM in the tail flick test and inhibited the effect of DM against the incisional pain. Intrathecal hemicholinium-3 (HC-3), a reversible inhibitor of choline transporter, did not change the effect of BCh in the tail flick test but produced a non-significant reduction of the effect of BCh against incisional pain. In contrast, HC-3 produced a non-significant reduction of the effect of DM in the tail flick test but fully inhibited the effect of DM against incisional pain. Therefore, the BCh-induced antinociception depends on a direct activation of muscarinic receptors, whereas DM-induced antinociception results in drug interaction with nicotinic receptors to activate the further release of acetylcholine from intrinsic spinal cholinergic terminals. The acetylcholine released by DM in turn induces antinociception via activation of muscarinic receptors.
Subject(s)
Analgesics/administration & dosage , Bethanechol/administration & dosage , Cholinergic Agonists/administration & dosage , Dimethylphenylpiperazinium Iodide/administration & dosage , Pain/drug therapy , Acetylcholine/physiology , Analysis of Variance , Animals , Atropine/pharmacology , Cholinergic Antagonists/pharmacology , Disease Models, Animal , Drug Interactions , Hemicholinium 3/pharmacology , Injections, Spinal , Male , Mecamylamine/pharmacology , Multivariate Analysis , Neurotransmitter Uptake Inhibitors/pharmacology , Pain/etiology , Rats , Rats, Wistar , Reaction Time/drug effects , Wounds and Injuries/complicationsABSTRACT
Synthesis of acetylcholine depends on the plasma membrane uptake of choline by a high affinity choline transporter (CHT1). Choline uptake is regulated by nerve impulses and trafficking of an intracellular pool of CHT1 to the plasma membrane may be important for this regulation. We have generated a hemagglutinin (HA) epitope tagged CHT1 to investigate the organelles involved with intracellular trafficking of this protein. Expression of CHT1-HA in HEK 293 cells establishes Na+-dependent, hemicholinium-3 sensitive high-affinity choline transport activity. Confocal microscopy reveals that CHT1-HA is found predominantly in intracellular organelles in three different cell lines. Importantly, CHT1-HA seems to be continuously cycling between the plasma membrane and endocytic organelles via a constitutive clathrin-mediated endocytic pathway. In a neuronal cell line, CHT1-HA colocalizes with the early endocytic marker green fluorescent protein (GFP)-Rab 5 and with two markers of synaptic-like vesicles, VAMP-myc and GFP-VAChT, suggesting that in cultured cells CHT1 is present mainly in organelles of endocytic origin. Subcellular fractionation and immunoisolation of organelles from rat brain indicate that CHT1 is present in synaptic vesicles. We propose that intracellular CHT1 can be recruited during stimulation to increase choline uptake in nerve terminals.
Subject(s)
Clathrin/metabolism , Endocytosis/physiology , Endosomes/metabolism , Hemicholinium 3/pharmacology , Membrane Transport Proteins/metabolism , Synaptic Vesicles/metabolism , Vesicular Transport Proteins , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Line , Humans , Kidney/cytology , Kidney/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Membrane Transport Proteins/drug effects , Membrane Transport Proteins/genetics , Mice , Neurons/cytology , Neurons/metabolism , R-SNARE Proteins , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Synaptosomes/metabolism , Vesicular Acetylcholine Transport ProteinsABSTRACT
Cytokines play a fundamental role during development of the nervous system. In this work we demonstrate the effect of IL-2 and IL-4 on [(3)H]choline uptake by retinal cells in vitro. Treatments with both interleukins induced a twofold increase on [(3)H]choline uptake. This effect was dose- and time-dependent and inhibited by specific antibodies as well as by inhibition either of protein kinase C or tyrosine kinase activity or of the cytoplasmatic calcium level increase. A synergistic effect was obtained with low concentration of IL-2 (5 U ml(-1)) and IL-4 (0.5 U ml(-1)). However, high concentrations of IL-2 (50 U ml(-1)) and IL-4 (5 U ml(-1)) elicited an antagonistic effect. Our data indicate an important role for interleukins during retinal development.
Subject(s)
Egtazic Acid/analogs & derivatives , Interleukin-2/pharmacology , Interleukin-4/pharmacology , Retina/cytology , Animals , Antibodies/pharmacology , Calcium/metabolism , Cells, Cultured , Chelating Agents/pharmacology , Choline/pharmacokinetics , Cholinergic Agents/pharmacology , Dose-Response Relationship, Drug , Drug Synergism , Egtazic Acid/pharmacology , Enzyme Inhibitors/pharmacology , Genistein/pharmacology , Hemicholinium 3/pharmacology , Interleukin-2/immunology , Interleukin-4/immunology , Neutralization Tests , Protein Kinase C/metabolism , Protein-Tyrosine Kinases/metabolism , Rats , Rats, Inbred Strains , Retina/drug effects , Retina/enzymology , TritiumABSTRACT
In the lateral septal area of spontaneously hypertensive rats, but not in Wistar-Kyoto rats, the selective M1 antagonist, pirenzepine, and the depletion of acetylcholine storage, by hemicholinium-3 (HC-3), decreased blood pressure. The selective M1 agonist McNeil-A-343, produced a pressor response only after treatment of the lateral septal area with HC-3 in spontaneously hypertensive rats. Carbachol, at doses that mainly affect M2 muscarinic receptors, caused no cardiovascular changes in either strain, pointing to the main intervention of the M1 subtype of muscarinic receptor in the hypertensive condition. In addition, increases in the density of binding sites for [3H]QNB and in Vmax of sodium-dependent, HC-3-inhibitable, high affinity uptake of choline were demonstrated, without significant changes of the activity of choline acetyltransferase in the lateral septal area of spontaneously hypertensive rats. These results suggest that a hyperactivity of the cholinergic system of this area could play a role in the development and/or maintenance of hypertension in spontaneously hypertensive rats.
Subject(s)
Blood Pressure/drug effects , Hemicholinium 3/pharmacology , Pirenzepine/pharmacology , Septum Pellucidum/physiology , (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride/pharmacology , Animals , Blood Pressure/physiology , Choline/metabolism , Choline O-Acetyltransferase/metabolism , Dose-Response Relationship, Drug , Male , Quinuclidinyl Benzilate/metabolism , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Receptors, Cholinergic/metabolism , Synaptosomes/metabolismABSTRACT
1. The effects of hemicholinium (HC-3) on several autonomic agents in the isolated rat vas deferens were investigated. 2. HC-3 reduced slightly the effects of NE and DA. 3. The responses by cholinergic agents on the M1-ACh receptors were not modified, however HC-3 reduced, significantly, the responses on the M2-ACh receptors. 4. These results suggest that HC-3 besides its anticholinergic properties possesses ability to interact with adrenoceptors in the isolated rat vas deferens.
Subject(s)
Autonomic Agents/pharmacology , Hemicholinium 3/pharmacology , Muscle, Smooth/metabolism , Receptors, Adrenergic/drug effects , Receptors, Cholinergic/drug effects , Animals , Dopamine/pharmacology , Electric Stimulation , In Vitro Techniques , Male , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Norepinephrine/pharmacology , Parasympathomimetics/pharmacology , Rats , Rats, Inbred StrainsABSTRACT
A histological, physiological and pharmacological study of two regions of the isolated uterine muscle of the rat., i.e., the myometrial one (a zone close to the mesometrial insertion) and the linea uteri (the antimesometrial zone) was performed. From the histological point of view the linea uteri (LU) is characterized by the presence of small bundles of longitudinal smooth muscle fibers (20 to 50), closely packed and clearly surrounded by a connective tissue, whereas in the myometrial zone (M) the smooth muscle fibers are less closely packed and the connective tissue is surrounding a greater number of them. The spontaneous oxytocin or electrically-induced initial tension developed by the LU or the M, was similar. Also the stability with time did not differ between both regions. Atropine depressed consistently the isometric developed tension of M strips, either spontaneously active or driven by oxytocin or electrical stimulation, but had no action on the mechanical activity of preparations from the LU. A pretreatment with hemicholinium also inhibited the spontaneous as well the oxytocin-induced motility of M strips, without affecting those of LU. Pharmacologic evidences suggest that acetylcholine may play a "facilitating" role in M strips for the conduction of coordinate contractions. This does not appear to be the case in the LU, which has the required characteristics to be recognized as a conductive like tissue.